Christina Canil

5.5k total citations
40 papers, 609 citations indexed

About

Christina Canil is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Christina Canil has authored 40 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 12 papers in Surgery. Recurrent topics in Christina Canil's work include Renal cell carcinoma treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Renal and related cancers (7 papers). Christina Canil is often cited by papers focused on Renal cell carcinoma treatment (14 papers), Prostate Cancer Treatment and Research (12 papers) and Renal and related cancers (7 papers). Christina Canil collaborates with scholars based in Canada, United States and India. Christina Canil's co-authors include Michael Ong, Daniel Y.C. Heng, Sébastien J. Hotte, Greg Knoll, Todd Fairhead, Toni K. Choueiri, Benoit Beuselinck, J. Connor Wells, Lori Wood and Camillo Porta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Christina Canil

39 papers receiving 603 citations

Peers

Christina Canil

ONCOL

PRM

SURGE

L. Quéro France

I. A. Small Brazil

Chonlakiet Khorprasert Thailand

J.-J. Patard France

Federico de la Rosa Spain

Arife Ulaş Türkiye

Milena Perez Mak Brazil

F. Desgrandchamps France

Kenneth Seier United States

Nicholas M. Donin United States

L. Quéro France

Christina Canil

256 ×0.8

ONCOL

329 ×1.1

PRM

88 ×0.6

239 ×1.7

SURGE

95 ×1.0

Citations per year, relative to Christina Canil Christina Canil (= 1×) peers L. Quéro

Countries citing papers authored by Christina Canil

Since Specialization

Citations

This map shows the geographic impact of Christina Canil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Canil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Canil more than expected).

Fields of papers citing papers by Christina Canil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Canil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Canil. The network helps show where Christina Canil may publish in the future.

Co-authorship network of co-authors of Christina Canil

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Canil. A scholar is included among the top collaborators of Christina Canil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Canil. Christina Canil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghosh, Sunita, Lori Wood, C. Kollmannsberger, et al.. (2025). Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients. Cancers. 17(3). 522–522. 2 indexed citations

Tanguay, Simon, Lori Wood, C. Kollmannsberger, et al.. (2025). Optimal Timing of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Patients Considering Sarcomatoid Status: A Real-World Study. Clinical Genitourinary Cancer. 23(3). 102342–102342. 1 indexed citations

Martel, Guillaume, Kimberly A. Bertens, & Christina Canil. (2024). Surgical Management of Genitourinary Cancer Liver Metastases. Hematology/Oncology Clinics of North America. 39(1). 89–102. 1 indexed citations

N., Kim, Christina Canil, Nimira Alimohamed, Denis Soulières, & Rodney H. Breau. (2023). 2023 European Society for Medical Oncology (ESMO) Congress. Canadian Urological Association Journal. 18(1). E46–52. 5 indexed citations

Dragomir, Alice, Lori Wood, Christian Kollmannsberger, et al.. (2023). Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies. European Urology Oncology. 7(3). 570–580. 5 indexed citations

Wood, Lori, Robert J. Hamilton, Piotr Czaykowski, et al.. (2022). Testicular cancer survivorship: Long-term toxicity and management. Canadian Urological Association Journal. 16(8). 257–272. 12 indexed citations

Zhang, Liying, Eric Winquist, Christina Canil, et al.. (2022). UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancer. Urologic Oncology Seminars and Original Investigations. 40(12). 539.e17–539.e22. 1 indexed citations

Clemons, Mark, Sharon F. McGee, Lisa Vandermeer, et al.. (2021). Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey. Supportive Care in Cancer. 29(11). 6903–6912. 6 indexed citations

Jiang, Di, Scott North, Christina Canil, et al.. (2020). Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada. Bladder Cancer. 6(3). 363–392. 2 indexed citations

10.

Martel, Guillaume, Kimberly A. Bertens, & Christina Canil. (2020). Surgical Management of Genitourinary Cancer Liver Metastases. Surgical Oncology Clinics of North America. 30(1). 89–102. 3 indexed citations

11.

Hotte, Sébastien J., Antonio Finelli, Kim N., et al.. (2020). Real-world management of advanced prostate cancer: A description of management practices of community-based physicians and prostate cancer specialists. Canadian Urological Association Journal. 15(2). E90–E96. 4 indexed citations

12.

Kushnir, Igal, Ranjeeta Mallick, Michael Ong, et al.. (2020). Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer. Cancer Chemotherapy and Pharmacology. 85(5). 863–868. 4 indexed citations

13.

Lalani, Aly‐Khan A., Kim N., Daniel Yick Chin Heng, et al.. (2020). Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic. Canadian Urological Association Journal. 14(5). E154–E158. 14 indexed citations

14.

Fernandes, Ricardo, Sasha Mazzarello, Anil A. Joy, et al.. (2018). Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study. Supportive Care in Cancer. 26(9). 3073–3081. 14 indexed citations

15.

Jones, Jennifer M., Jaimin R. Bhatt, Andreas Laupacis, et al.. (2017). The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians. Canadian Urological Association Journal. 11(12). 379–87. 27 indexed citations

16.

Ong, Michael, et al.. (2016). Antitumor activity of nivolumab on hemodialysis after renal allograft rejection. Journal for ImmunoTherapy of Cancer. 4(1). 64–64. 72 indexed citations

17.

Richter, Suzanne, Joseph D. Ruether, Lori Wood, et al.. (2013). Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). Canadian Urological Association Journal. 7(11-12). 797–797. 11 indexed citations

18.

Canil, Christina, et al.. (2013). Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell carcinoma: a systematic review. Canadian Urological Association Journal. 4(3). 201–201. 17 indexed citations

19.

Chow, Laura Q.M., Normand Blais, Derek J. Jonker, et al.. (2011). A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with pemetrexed in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 69(3). 709–722. 11 indexed citations

20.

Malone, Shawn, et al.. (2010). Primary skull-based yolk-sac tumour: case report and review of central nervous system germ cell tumours. Journal of Neuro-Oncology. 101(1). 129–134. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact